Stockreport

Celcuity outlines potential $2.5B annual peak revenue for gedatolisib amid pivotal clinical milestones and commercial launch preparations [Seeking Alpha]

Celcuity Inc.  (CELC) 
Last celcuity inc. earnings: 3/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: celcuity.com/home/investors
PDF CEO Brian Sullivan highlighted that 2025 was pivotal for Celcuity, stating the company is preparing for "the potential approval and commercialization of gedatolisib." H [Read more]